ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,499Medicare Part D Prescriptions Filled, Including Refills

Rank: 381 out of 2652

$616K Total Retail Price of All Prescriptions

Rank: 356 out of 2652

351 Patients Receiving at Least One Drug in Part D
65% Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Illinois
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

11% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

20% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Illinois
AMLODIPINE BESYLATE 415 282 68 1 3
LEVOTHYROXINE SODIUM 336 234 50 2 2
PRAVASTATIN SODIUM 310 180 52 3 19
FUROSEMIDE 287 176 50 4 5
HYDROCODONE-ACETAMINOPHEN 265 119 53 S3 5 8
OMEPRAZOLE 256 100 57 6 7
METFORMIN HCL 247 171 38 7 9
ATORVASTATIN CALCIUM 246 165 51 8 6
WARFARIN SODIUM 223 180 19 9 11
LISINOPRIL 209 109 39 10 4
TRAMADOL HCL 186 113 53 11 22
SIMVASTATIN 172 141 36 12 1
LOSARTAN POTASSIUM 153 127 29 13 14
GABAPENTIN 137 86 38 14 18
NAMENDA 135 <11 <11 15 25
METOPROLOL SUCCINATE 129 95 25 16 12
ALLOPURINOL 127 90 20 17 30
HYDROCHLOROTHIAZIDE 125 96 29 18 13
LORAZEPAM 121 108 27 B 19 35
CLOPIDOGREL 114 75 18 20 15
SERTRALINE HCL 106 51 19 21 27
FLUTICASONE PROPIONATE 105 53 47 22 38
METOPROLOL TARTRATE 104 68 27 23 10
DONEPEZIL HCL 103 103 14 24 24
ATENOLOL 99 62 19 25 17
ACETAMINOPHEN-CODEINE 95 69 20 S3 26 93
DIOVAN 95 90* 12 26 33
POLYETHYLENE GLYCOL 3350 92 44 20 28 62
ADVAIR DISKUS 91 67 26 29 49
SPIRIVA 87 59 14 30 63
KLOR-CON M20 83 47 17 31 57
CYMBALTA 80 62 12 32 60
RANITIDINE HCL 79 42 11 33 42
LOSARTAN-HYDROCHLOROTHIAZIDE 77 47 13 34 55
PANTOPRAZOLE SODIUM 75 45 13 35 20
PROAIR HFA 74 26 29 36 39
ZOLPIDEM TARTRATE 72 36 14 37 32
POTASSIUM CHLORIDE 72 43 23 37 16
LYRICA 70 52 12 39 95
AMITRIPTYLINE HCL 69 44 14 R 40 96
BACLOFEN 68 <11 17 41 125
MONTELUKAST SODIUM 65 49 13 42 50
ALENDRONATE SODIUM 64 <11 <11 43 28
CARVEDILOL 64 59* 15 43 21
LANTUS SOLOSTAR 62 18 15 45 75
TRAZODONE HCL 61 32 19 46 58
GLIPIZIDE 61 46 11 46 44
LOVASTATIN 60 55* 14 48 37
BD ULTRA-FINE PEN NEEDLE 59 31 19 49 105
CLONAZEPAM 56 <11 <11 B 50 71
QUETIAPINE FUMARATE 54 <11 <11 A 51 59
LANTUS 53 <11 <11 52 56
OXYCODONE-ACETAMINOPHEN 52 26 20 S2 53 209
NOVOLOG MIX 70-30 FLEXPEN 51 <11 <11 54 275
CITALOPRAM HBR 51 46* 11 54 31
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.